Pharmacological studies on 1-methyl-7-nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (S-1530).
D000374:Aggression / Q000187:drug effects; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001362:Avoidance Learning / Q000187:drug effects; D001552:Benzazepines / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects*; D003984:Dibenzazepines / Q000633:toxicity; D004569:Electroencephalography; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology; D008297:Male; D008694:Methamphetamine / Q000037:antagonists & inhibitors; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009574:Nitro Compounds / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012890:Sleep / Q000187:drug effects
D000927:Anticonvulsants; D001552:Benzazepines; D003984:Dibenzazepines; D006993:Hypnotics and Sedatives; D007659:Ketones; D009125:Muscle Relaxants, Central; D009574:Nitro Compounds; D008694:Methamphetamine; D001058:Apomorphine; D004837:Epinephrine